This brand name is authorized in Nigeria. It is also authorized in Australia, Ecuador, France, Malta, Mexico, Poland, Romania, Singapore, South Africa.
The drug ZENTEL contains one active pharmaceutical ingredient (API):
1
|
UNII
F4216019LN - ALBENDAZOLE
|
|
Albendazole causes degenerative alterations in the tegument and intestinal cells of the worm by binding to the colchicine-sensitive site of tubulin, thus inhibiting its polymerization or assembly into microtubules. |
|
This drug has been approved in Nigeria as follows:
| Identifier | Form | Presentation | Description | Approval |
|---|---|---|---|---|
| 04-2400 | Tablet | ZENTEL TABLETS TAB 200 mg 12tablets | ZENTEL TABLETS ALBENDAZOLE 200MG Albendazole USP 200mg Apr-00 Drugs Imported Products 12tablets POM 1 01/02/2023 GLAXO SMITHKLINE CONSUMER NIGERIA PLC, INDUSTRIAL AVENUE, ILUPEJU LAGOS LAGOS 12711000 regulatoryconsumer@gsk.com Medreich Limited 4/3 Avalahalli, Anjanapura Post Off Kanakapura Road Bangalore- 560 062, INDIA | 26/04/2023 |
| 04-2467 | Suspension | Zentel suspension SUSP 100 mg/5 mL 20ml | 47 RNW-PP-252448 Zentel suspension ALBENDAZOLE Active ingredient - Albendazole 100mg/5ml, List of Excipients 1. Sodium Lauryl sulphate 2. Glycerine 3. Methyl Hydroxy Benzoate 4. Propyl Hydroxy Benzoate 5. Carmellose Sodium (Sodium Carboxy Methylcellulose) 6. Sorbitol Solution 70% 7. Orange Flavour 8. Passion Fruit Flavour 9. Vanilla Extra Strong 10. Purified Water 11. Citric acid Apr-67 Drugs Imported Products 20ml Prescription Only Medicine (POM) 2/17/2022 GLAXO SMITHKLINE CONSUMER NIGERIA PLC, INDUSTRIAL AVENUE, ILUPEJU LAGOS LAGOS 12711000 regulatoryconsumer@gsk.com Panacea Biotec Pharma Ltd, Malpur Baddi, Tehsil Nalagarh, Solan, Himachal Pradesh 173205 India, India | 06/07/2023 |
This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:
| ATC Group | Classification | |
|---|---|---|
| P02CA03 | Albendazole | P Antiparasitic products, insecticides and repellents → P02 Anthelmintics → P02C Antinematodal agents → P02CA Benzimidazole derivatives |
This drug has been assigned below unique identifiers within the countries it is being marketed:
| Country | Identification scheme | Identifier(s) |
|---|---|---|
| AU | Pharmaceutical Benefits Scheme | 8503M, 9047E |
| EC | Agencia Nacional de Regulación, Control y Vigilancia Sanitaria | 25.042-04-03, 25.043-04-03, 6927-MEE-0122, 7146-MEE-0322 |
| FR | Base de données publique des médicaments | 65565944, 69731801 |
| MT | Medicines Authority | AA565/32802 |
| MX | Comisión Federal para la Protección contra Riesgos Sanitarios | 036M82, 037M82 |
| NG | Registered Drug Product Database | 04-2400, 04-2467 |
| PL | Rejestru Produktów Leczniczych | 100072539, 100246577, 100292979, 100293654, 100300213, 100300590, 100308924, 100309183, 100324509, 100324685, 100324900, 100326112, 100326170, 100326879, 100330734, 100336820, 100344570, 100346617, 100350369, 100354999, 100355208, 100357555, 100357845, 100358359, 100359985, 100367915, 100369759, 100378037, 100400883, 100419859, 100424040, 100425720, 100436852, 100439081, 100440078, 100454073 |
| RO | Agenția Națională a Medicamentului și a Dispozitivelor Medicale | W65214001 |
| SG | Health Sciences Authority | 05406P, 14030P |
| ZA | Health Products Regulatory Authority | 30/12/0354, Q/12/75 |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.